Stockscreener 앱 받기
16.99
0.18%
0.03
Gh Research Plc 주식(GHRS)의 최신 뉴스
GH Research (GHRS) Is Up 9.1% After FDA Lifts Clinical Hold On GH001 Depression Drug - simplywall.st
Aug Setups: Whats the profit margin of GH Research PLCJuly 2025 Fed Impact & Precise Entry and Exit Recommendations - baoquankhu1.vn
What is the dividend yield of GH Research PLCPortfolio Update Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
CEO Change: Is GH Research PLC a turnaround story2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Is GH Research PLC stock undervalued right now2025 Key Highlights & Weekly High Momentum Picks - bollywoodhelpline.com
Aug Setups: Is GH Research PLC stock supported by strong fundamentalsJuly 2025 Summary & Verified Entry Point Detection - Bộ Nội Vụ
GH Research Showcases Positive GH001 Phase 2b Data in Treatment-Resistant Depression at ACNP 2026 - TipRanks
How FDA’s Lifted Clinical Hold On GH001 At GH Research (GHRS) Has Changed Its Investment Story - Yahoo Finance
Responsive Playbooks and the GHRS Inflection - Stock Traders Daily
EBIT per share of GH Research Plc – FWB:1KA - TradingView — Track All Markets
GH Research PLC (GHRS) Stock Analysis: 109.70% Upside Potential Amid Promising Biotech Innovations - DirectorsTalk Interviews
Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - MSN
Will GH Research PLC (1KA) stock profit from fiscal stimulusStability vs Neutral Overview & lightweight options for faster days - Улправда
Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December - Sahm
Assessing GH Research (GHRS) Valuation After FDA Lifts Clinical Hold On GH001 IND - Sahm
Is GH Research PLC (1KA) stock protected from inflationTrade Ideas & Low Risk Entry Point Tips - Улправда
Why analysts maintain buy rating on GH Research PLC (1KA) stock2025 Market Overview & Low Risk Profit Maximizing Plans - Улправда
Risk Analysis: How institutional buying supports GH Research PLC stockTrend Reversal & High Accuracy Investment Entry Signals - ulpravda.ru
Published on: 2026-01-09 02:32:55 - Улправда
GH Research PLCOrdinary Shares (NQ: GHRS - FinancialContent
What dividend safety score for GH Research PLC stockEarnings Risk Report & Low Risk High Reward Trade Ideas - ulpravda.ru
How strong is GH Research PLC stock balance sheet2025 Valuation Update & Weekly High Conviction Ideas - Улправда
Quarterly Recap: What dividend safety score for GH Research PLC stock2025 Top Gainers & Weekly High Conviction Trade Ideas - Улправда
GH Research to Present Six-Month Safety and Efficacy Data on Inhaled GH001 in Depression at 2026 ACNP Meeting - TipRanks
Why is GHRS stock rising today? - MSN
Assessing GH Research (GHRS) Valuation After FDA Lifts Clinical Hold On GH001 Trials - Yahoo Finance
Stock market today: S&P 500, Nasdaq futures rise, WTI fluctuates following US strike on Venezuela—GH Research, Vertiv Holdings, Nukkleus in focus - MSN
Why Is GHRS Stock Rising Today? - Asianet Newsable
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment - Asianet Newsable
What drives GH Research PLC stock priceDividend Reinvestment Plans & Outstanding Capital Tips - earlytimes.in
GH Research (NASDAQ:GHRS) Stock Price Up 6.9%Should You Buy? - MarketBeat
Will GH Research PLC (1KA) stock gain from green policies2026 world cup usa national team round of 32 playmakers pressing system odds analysis tactical review - Улправда
GH Research (NASDAQ:GHRS) Stock Price Down 9.2%Should You Sell? - MarketBeat
GH Research stock price target raised to $29 from $19 at Needham - Investing.com Nigeria
GH Research stock jumps as Canaccord raises price target on FDA hold lift - Investing.com Nigeria
GH Research stock price target raised to $29 from $19 at Needham By Investing.com - Investing.com South Africa
GH Research stock rises as FDA lifts clinical hold on GH001 By Investing.com - Investing.com South Africa
GH Research stock jumps as Canaccord raises price target on FDA hold lift By Investing.com - Investing.com South Africa
GH Research stock rises as FDA lifts clinical hold on GH001 - Investing.com Australia
GHRS Stock Sees Significant Price Target Increase by Needham | G - GuruFocus
GH Research (GHRS) Is Up 24.2% After FDA Lifts Hold On GH001 U.S. Trial Enrollment - simplywall.st
Hold lifted, as GH Research preps for pivotal GH-001 depression trial - BioWorld MedTech
GH Research stock rating reiterated as Buy by TD Cowen - Investing.com South Africa
Psychedelics-Tied GH Skyrockets On FDA Go-Ahead For Depression Drug - Investor's Business Daily
GH Research says FDA lifts clinical hold on GH001 - TipRanks
GH Research stock rises as FDA lifts clinical hold on inhaled 5-MeO-DMT By Investing.com - Investing.com South Africa
GH Research (NASDAQ:GHRS) Shares Gap UpTime to Buy? - MarketBeat
GH Research stock rises as Stifel reiterates Buy rating after clinical hold lifted By Investing.com - Investing.com South Africa
GH Research stock rises as FDA lifts clinical hold on inhaled 5-MeO-DMT - Investing.com Nigeria
4.73%
0.92%
자본화:
|
볼륨(24시간):